Indikation zur prä-, post- und intraoperativen Strahlentherapie von Liposarkomen des Erwachsenenalters

Zusammenfassung

Radiotherapie ist ein integraler Bestandteil der Behandlung von Weichteilsarkomen des Erwachsenen. Während die Indikationsstellung zur additiven Radiotherapie bisher im Wesentlichen auf den bekannten allgemeinen Prognosefaktoren wie Tumorgröße, Lokalisation, Grading und (antizipiertem) Resektionsrand basierte, rückt der histologische Subtyp jetzt zunehmend in den Vordergrund. Außerdem haben sich die radiotherapeutischen Techniken deutlich weiterentwickelt, sodass eine adäquate Therapie in einigen Lokalisationen überhaupt erst möglich geworden ist. Diese Übersichtsarbeit fasst daher zunächst die allgemeinen radioonkologischen Therapieprinzipien für alle Weichteilsarkome, getrennt für die Hauptlokalisationen Extremitäten/Körperstamm und Retroperitoneum, zusammen. Dabei werden sowohl die vorliegende Evidenz für eine additive Radiotherapie per se als auch das optimale Timing (prä- vs. postoperativ) sowie grundlegende technische Prinzipien einschl. alternativer Boostverfahren wie der intraoperativen Radiotherapie erörtert. Weiterhin liegt ein besonderer Schwerpunkt auf der Indikation und Durchführung einer additiven Radiotherapie bei Liposarkomen. Hierzu werden sowohl die grundlegenden Unterschiede zwischen Liposarkomen und anderen Weichteilsarkomen als auch zwischen den einzelnen Subgruppen der Liposarkome (gut differenziert, dedifferenziert, myxoid und pleomorph) dargestellt und ihre Implikationen auf Indikationsstellung und Durchführung einer additiven Radiotherapie mit dem Ziel einer übersichtlichen Orientierungshilfe erörtert.

Abstract

Radiation therapy is an integral part of the treatment of soft tissue sarcomas in adults. The indication for additional radiation therapy has usually been based on known general prognostic factors, such as tumour size, localisation, grading and (anticipated) resection margin. Increasing attention has recently been paid to the role of the histological subtype. Moreover, radiation therapy techniques have distinctly improved, so that in some localisations adequate treatment has become possible for the first time. This review firstly summarises general treatment principles of radiation therapy in soft tissue sarcomas – separately for the extremities and trunk and the retroperitoneum. We discuss the available evidence for the administration of additional radiation per se, the preferred timing (pre- vs. postoperative) and fundamental technical principles, including alternative boosting techniques like intraoperative radiation therapy. Moreover, we provide a detailed discussion of the indication and procedure for additional radiation therapy in liposarcomas. We describe fundamental differences between liposarcomas and other soft tissue sarcomas as well as between the subgroups of liposarcoma (well differentiated, dedifferentiated, myxoid, pleomorphic), and how this affects the indication and procedure for additional radiation therapy, in order to provide a panoramic aid to orientation.

Schlüsselwörter

Strahlentherapie - Sarkom - Liposarkom

Key words

radiation therapy - sarcoma - liposarcoma

• Literatur

• 1 National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology (NCCN Guidelines) Soft Tissue Sarcoma Version 2.2019. Im Internet: http://www.nccn.org Stand: 02.01.2020
• 2 Casali PG, Abecassis N, Aro HT. et al. ESMO Guidelines Committee and EURACAN. Soft-tissue and visceral sarcoma: ESMO-EURACAN Clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29 (Suppl.) iv51-iv67
• 3 Jebsen NL, Trovik CS, Bauer HC. et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys 2008; 71: 1196-1203
• 4 Rosenberg SA, Tepper J, Glatstein E. et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations (1) of limb-sparing surgery plus radiation therapy compared with amputation an (2) the role of adjuvant chemotherapy. Ann Surg 1982; 196: 305-314
• 5 Yang JC, Chang AE, Baker AR. et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998; 16: 197-203
• 6 Callegaro D, Miceli R, Bonvalot S. et al. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. Eur J Cancer 2018; 105: 19-27
• 7 Albertsmeier M, Rauch A, Roeder F. et al. External beam radiation therapy for resectable soft tissue sarcoma: a systematic review and meta-analysis. Ann Surg Oncol 2018; 25: 754-767
• 8 Koshy M, Rich SE, Mohiuddin MM. Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a SEER analysis. Int J Radiat Oncol Biol Phys 2010; 77: 203-209
• 9 OʼSullivan B, Davis AM, Turcotte R. et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomized trial. Lancet 2002; 359: 2235-2241
• 10 Le Grange F, Cassoni AM, Seddon BM. Tumor volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma. Eur J Surg Oncol 2014; 40: 394-401
• 11 Stacchiotti S, Collini P, Messina A. et al. High-grade soft-tissue sarcomas: tumor response assessment – pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology 2009; 251: 447-456
• 12 Davis AM, OʼSullivan B, Turcotte R. et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005; 75: 48-53
• 13 Folkert MR, Singer S, Brennan MF. et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol 2014; 32: 3236-3241
• 14 Dickie CI, Parent AL, Chung PW. et al. Measuring interfractional and intrafractional motion with cone beam computed tomography and an optical localization system for lower extremity soft tissue sarcoma patients treated with preoperative intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2010; 78: 1437-1444
• 15 Delaney TF, Haas RL. Innovative radiotherapy of sarcoma: proton beam radiation. Eur J Cancer 2016; 62: 112-123
• 16 Haas RL, Delaney TF, OʼSullivan B. et al. Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?. Int J Radiat Oncol Biol Phys 2012; 84: 572-580
• 17 Alamanda VK, Song Y, Shinohara E. et al. Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas. J Med Imaging Radiat Oncol 2014; 58: 633-640
• 18 Roeder F, Schulz-Erter D, Nikoghosyan AV. et al. A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma. BMC Cancer 2012; 12: 287
• 19 Toulmonde M, Bonvalot S, Meeus P. et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French sarcoma group. Ann Oncol 2014; 25: 735-742
• 20 Gronchi A, Strauss DC, Miceli R. et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg 2016; 263: 1002-1009
• 21 Leiting JL, Bergquist JR, Hernandez MC. et al. Radiation therapy for retroperitoneal sarcomas: influences of histology, grade, and size. Sarcoma 2018; 5: 7972389 doi:10.1155/2018/7972389
• 22 Nussbaum DP, Rushing CN, Lane WO. et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol 2016; 17: 966-975
• 23 Bonvalot S, Gronchi A, Le Pechoux C. et al. STRASS (EORTC62092): A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. J Clin Oncol 2019; 37 (Suppl.) S11001
• 24 Roeder F, Ulrich A, Habl G. et al. Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis. BMC Cancer 2014; 14: 617
• 25 Swanson EL, Indelicato DJ, Louis D. et al. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys 2012; 83: 1549-1557
• 26 Wong P, Dickie C, Lee D. et al. Spatial and volumetric changes of retroperitoneal sarcomas during pre-operative radiotherapy. Radiother Oncol 2014; 112: 308-313
• 27 Baldini EH, Wang D, Haas RL. et al. Treatment guidelines for preoperative radiation therapy for retroperitoneal sarcoma: preliminary consensus of an international expert panel. Int J Radiat Oncol Biol Phys 2015; 92: 602-612
• 28 Tzeng CW, Fiveash JB, Popple RA. et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 2006; 107: 371-379
• 29 DeLaney TF. Fine tuning the radiation treatment for extremity soft tissue sarcomas. Ann Surg Oncol 2018; 25: 3785-3786
• 30 Roeder F, Krempien R. Intraoperative radiation therapy (IORT) in soft-tissue sarcoma. Radiat Oncol 2017; 12: 20
• 31 Roeder F, Lehner B, Saleh-Ebrahimi L. et al. Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases. Radiother Oncol 2016; 119: 22-29
• 32 Roeder F, de Paoli A, Saleh-Ebrahimi L. et al. Intraoperative electron radiation therapy combined with external beam radiation therapy after gross total resection in extremity soft tissue sarcoma: a European pooled analysis. Ann Surg Oncol 2018; 25: 3833-3842
• 33 Roeder F, Lehner B, Schmitt T. et al. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial. BMC Cancer 2014; 14: 350
• 34 Gieschen HL, Spiro IJ, Suit HD. et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys 2001; 50: 127-131
• 35 Stucky CC, Wasif N, Ashman JB. et al. Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma. J Surg Oncol 2014; 109: 798-803
• 36 Kelly KJ, Yoon SS, Kuk D. et al. Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: a retrospective 2-institution study. Ann Surg 2015; 262: 156-162
• 37 Crago AM, Dickson MA. Liposarcoma: multimodality management and future targeted therapies. Surg Oncol Clin N Am 2016; 25: 761-773
• 38 Jo VY, Fletcher CD. WHO classification of soft tissue tumors: an update based on the 2013 (4th) edition. Pathology 2014; 46: 95-104
• 39 Petersen I, Wardelmann E. Grading von Weichgewebe- und Knochensarkomen. Pathologe 2016; 37: 320-327
• 40 Anderson WJ, Jo VY. Pleomorphic liposarcoma: updates and current differential diagnosis. Sem Diag Pathol 2019; 36: 122-128
• 41 Bartlett EK, Curtin CE, Seier K. et al. Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma. Ann Surg 2019; DOI: 10.1097/SLA.0000000000003453.
• 42 Cassier PA, Kantor G, Bonvalot S. et al. Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French sarcoma group (GSF-GETO) study. Ann Oncol 2014; 25: 1854-1860
• 43 Rauh J, Klein A, Bauer-Melnyk A. et al. The role of surgical margins in atypical lipomatous tumours of the extremities. BMC Musculoskelet Disord 2018; 19: 152
• 44 Fonseca AL, Roland CL, Cormier JN. et al. Radiation and its impact on local recurrence in extremity and trunk well-differentiated liposarcomas. Am Surg 2019; 85: 52-58
• 45 Haas R, Bonvalot S, Miceli R. et al. Radiotherapy for retroperitoneal liposarcoma: a report from the transatlantic retroperitoneal sarcoma working group. Cancer 2019; 125: 1290-1300
• 46 Chouliaras K, Senehi R, Ethun CG. et al. Recurrence patterns after resection of retroperitoneal sarcomas: an eight-institution study from the US sarcoma collaborative. J Surg Oncol 2019; 120: 340-347
• 47 Guadagnolo BA, Zagars GK, Ballo MT. et al. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 760-765
• 48 Dürr HR, Rauh J, Bauer-Melnyk A. et al. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients. BMC Cancer 2018; 8: 304
• 49 Chowdhry V, Goldberg S, DeLaney T. et al. Myxoid liposarcoma: treatment outcomes from chemotherapy and radiation therapy. Sarcoma 2018; 2018: 8029157 doi:10.1155/2018/8029157
• 50 Kosela-Paterczyk H, Szumera-Cieckiewicz A, Szacht M. et al. Efficacy of neoadjuvant hypofractionated radiotherapy in patients with locally advanced myxoid liposarcoma. Eur J Surg Oncol 2016; 42: 891-898
• 51 Gronchi A, Hindi N, Cruz J. et al. Trabectidin and Radiotherapy in soft tissue sarcoma (TRAST): Results of a phase I study in myxoid liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma groups. EClinicalMedicine 2019; 9: 35-43
• 52 Hornick JL, Bosenberg MW, Mentzel T. et al. Pleomorphic liposarcoma – clinicopathologic analysis of 57 cases. Am J Surg Pathol 2004; 28: 1257-1267
• 53 Petersen IA, Haddock MG, Donohue JH. et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002; 52: 469-475
• 54 Pawlik TM, Pisters PW, Mikula L. et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006; 13: 508-517
• 55 Gronchi A, De Paoli A, Dani C. et al. Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I–II study from the Italian Sarcoma Group. Eur J Cancer 2014; 50: 784-792
• 56 Smith MJ, Ridgway PF, Catton CN. et al. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Radiother Oncol 2014; 110: 165-171
• 57 Hull MA, Molina G, Niemierko A. et al. Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with combined with radical surgical resection for retroperitoneal sarcoma. J Surg Oncol 2017; 9999: 1-6